H-Wave® Device Stimulation for Post-operative Rotator Cuff Repair Surgery
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Electronic Waveform Lab
- Study ID
- NCT07501949
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Rotator Cuff Tear Surgical Repair
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Routine post-surgical care plus H-Wave® Device Stimulation (HWDS) — DEVICERoutine post-surgical care plus H-Wave® Device Stimulation (HWDS)
- Routine post-surgical care — OTHERRoutine post-surgical care: standard protocols per procedure, including access to opioid and non-opioid pain medications
Study Details
The goal of this intent-to-treat study is to evaluate the efficacy of H-Wave Device Stimulation following rotator cuff repair surgery. It is hypothesized that HWDS initiated immediately upon home arrival following rotator cuff repair will not only result in earlier range of motion recovery, but also in better pain relief, medication reduction, sleep quality, and functional recovery. The participants will be randomized into two groups: (a) Routine post-surgical care: standard protocols per procedure, including access to opioid and non-opioid pain medications, (b) Routine post-surgical care plus H-Wave® Device Stimulation (HWDS); and will be followed for 3 months post-surgery.
Key Dates
- Start date
- Apr 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Routine post-surgical care plus H-Wave® Device Stimulation (HWDS)
- Active Comparator: Routine post-surgical care
Primary Outcome Measure
Change in Pain Medication Usage [ Time Frame: Baseline, 6-8days, 3-4weeks, 2 months and 3 months ]
Central Contacts
- William J. Heaney Jr.213-268-2619
- Heather Gorman714-951-1917
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sano | Overland Park | Kansas | 66211 | Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR) Matthew Dagget, DO, MBA (SUB_INVESTIGATOR) Andrew Witte, DO, MBA (SUB_INVESTIGATOR) Matthew Cullen, DO (SUB_INVESTIGATOR) John Swab, DO (SUB_INVESTIGATOR) Christopher Eckland, DO (SUB_INVESTIGATOR) Daniel Farrell, MS, MD, FAAOS (SUB_INVESTIGATOR) |
| Sano | Kansas City | Missouri | 64151 | Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR) Matthew Dagget, DO, MBA (SUB_INVESTIGATOR) Andrew Witte, DO, MBA (SUB_INVESTIGATOR) Matthew Cullen, DO (SUB_INVESTIGATOR) John Swab, DO (SUB_INVESTIGATOR) Christopher Eckland, DO (SUB_INVESTIGATOR) |
| Sano | Lee's Summit | Missouri | 64064 | Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR) Matthew Dagget, DO, MBA (SUB_INVESTIGATOR) Andrew Witte, DO, MBA (SUB_INVESTIGATOR) Matthew Cullen, DO (SUB_INVESTIGATOR) John Swab, DO (SUB_INVESTIGATOR) Christopher Eckland, DO (SUB_INVESTIGATOR) |
| Sano | Raymore | Missouri | 64083 | Michael J. Dempewolf, DO, MBA (PRINCIPAL_INVESTIGATOR) Matthew Dagget, DO, MBA (SUB_INVESTIGATOR) Andrew Witte, DO, MBA (SUB_INVESTIGATOR) Matthew Cullen, DO (SUB_INVESTIGATOR) John Swab, DO (SUB_INVESTIGATOR) Christopher Eckland, DO (SUB_INVESTIGATOR) |